disulfiram has been researched along with Peritoneal Neoplasms in 2 studies
Peritoneal Neoplasms: Tumors or cancer of the PERITONEUM.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Zhang, T | 1 |
Kephart, J | 1 |
Bronson, E | 1 |
Anand, M | 1 |
Daly, C | 1 |
Spasojevic, I | 1 |
Bakthavatsalam, S | 1 |
Franz, K | 1 |
Berg, H | 1 |
Karachaliou, GS | 1 |
James, OG | 1 |
Howard, L | 1 |
Halabi, S | 1 |
Harrison, MR | 1 |
Armstrong, AJ | 1 |
George, DJ | 1 |
Wang, P | 1 |
Luo, Q | 1 |
Zhang, L | 1 |
Qu, X | 1 |
Che, X | 1 |
Cai, S | 1 |
Liu, Y | 1 |
1 trial available for disulfiram and Peritoneal Neoplasms
Article | Year |
---|---|
Prospective clinical trial of disulfiram plus copper in men with metastatic castration-resistant prostate cancer.
Topics: Copper; Disulfiram; Humans; Male; Peritoneal Neoplasms; Prospective Studies; Prostatic Neoplasms, Ca | 2022 |
1 other study available for disulfiram and Peritoneal Neoplasms
Article | Year |
---|---|
A disulfiram/copper gluconate co-loaded bi-layered long-term drug delivery system for intraperitoneal treatment of peritoneal carcinomatosis.
Topics: Animals; Cell Line, Tumor; Copper; Disulfiram; Drug Delivery Systems; Humans; Mice; Peritoneal Neopl | 2023 |